Home › NDC Lookup › RxCUI directory › RxCUI 977915

12 HR oxymorphone hydrochloride 40 MG Extended Release Oral Tablet — RxCUI 977915

RxNorm drug concept · Semantic clinical drug
RxCUI 977915 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 56 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI977915
Official name12 HR oxymorphone hydrochloride 40 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asoxyMORphone HCl 40 MG 12HR Extended Release Oral Tablet
FDA products mapped14
Package NDCs mapped56
Reported Medicaid activity (SDUD)2,486 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oxymorphone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The regular oxymorphone tablet is meant for short-term, acute pain — the kind that hits hard and needs quick relief for a limited time. You'd take it every four to six hours as nee...
  • What's the difference between the regular tablet and the extended-release tablet?
  • It's a real safety point, not just a suggestion. Eating a meal before taking oxymorphone — especially the extended-release version — can raise the amount of drug that gets into you...
  • Why does my pharmacist keep telling me to take this on an empty stomach?
📖 Read our full Oxymorphone guide →

🕸️ Concept Web — How 12 HR oxymorphone hydrochloride 40 MG Extended R... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 12 HR oxymorphone hydrochloride 40 MG Extended Release Oral Tablet RxCUI 977915

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Oxymorphone 7814
    • Oxymorphone hydrochloride 82064
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oxymorphone Extended Release Oral Tablet 643115
    • Oxymorphone hydrochloride Extended Release Oral Tablet 2645937
    • Oxymorphone Oral Product 1162252
    • Oxymorphone Pill 1162253
    • Oxymorphone hydrochloride Oral Product 2660073
    • Oxymorphone hydrochloride Pill 2659325
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Oxymorphone hydrochloride 40 MG 977914

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Oxymorphone hydrochloride 40 MG SCDC · 977914
  • Oxymorphone Extended Release Oral Tablet SCDF · 643115
  • Oxymorphone hydrochloride Extended Release Oral Tablet SCDFP · 2645937
  • Oxymorphone Oral Product SCDG · 1162252
  • Oxymorphone Pill SCDG · 1162253
  • Oxymorphone hydrochloride Oral Product SCDGP · 2660073
  • Oxymorphone hydrochloride Pill SCDGP · 2659325

📦 FDA Products & Package NDCs

14 products · 56 package NDCs
56 package NDCs map to RxCUI 977915 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64896-0700-08 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-... Oxymorphone hydrochloride Amneal Pharmaceuticals LLC 2013-01-02
64896-0700-13 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-... Oxymorphone hydrochloride Amneal Pharmaceuticals LLC 2013-01-02
64896-0701-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896... Oxymorphone hydrochloride Amneal Pharmaceuticals LLC 2013-01-02
64896-0701-03 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (6489... Oxymorphone hydrochloride Amneal Pharmaceuticals LLC 2013-01-02
64896-0701-08 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-... Oxymorphone hydrochloride Amneal Pharmaceuticals LLC 2013-01-02
64896-0701-13 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64896-... Oxymorphone hydrochloride Amneal Pharmaceuticals LLC 2013-01-02
Observed labelers: Amneal Pharmaceuticals LLC (28) · Amneal Pharmaceuticals of New York LLC (28) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.